Back
Mayne Pharma Group Ltd. 10K Form
Sell
28
MAYNF
Mayne Pharma Group Ltd.
Last Price:
$2.36
Seasonality Move:
-4.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MAYNF News And Ratings
See the #1 stock for the next 7 days that we like better than MAYNF
MAYNF Financial Statistics
Sales & Book Value
| Annual Sales: | $264.3M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.42 |
| Price / Book: | 0.96 |
Profitability
| EPS (TTM): | -0.76350 |
|---|---|
| Net Income (TTM): | $-57.7M |
| Gross Margin: | $120.6M |
| Return on Equity: | -26.72% |
| Return on Assets: | -11.32% |
Mayne Pharma Group Ltd. Earnings Forecast
Key Mayne Pharma Group Ltd. Financial Ratios
-
The Gross Profit Margin over the past 16 years for MAYNF is 45.64%.
-
The Selling, General & Administrative Expenses for MAYNF have been equal to 33.53% of Gross Profit Margin.
-
The Research & Development expenses have been 4.39% of Revenue.
-
The Net Earning history of MAYNF is -22.07% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 10 years.
Mayne Pharma Group Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MAYNF |
| Website: | maynepharma.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 1.4 |
| Quick Ratio: | 1.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.7 |
|---|---|
| Forward P/E Ratio: | 0 |
MAYNF Technical Analysis vs Fundamental Analysis
Sell
28
Mayne Pharma Group Ltd. (MAYNF)
is a Sell
Is Mayne Pharma Group Ltd. a Buy or a Sell?
-
Mayne Pharma Group Ltd. stock is rated a SellThe current Mayne Pharma Group Ltd. [MAYNF] share price is $2.36. The Score for MAYNF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.